Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
Clinical Genitourinary Cancer
|
December 3, 2014
Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma
Guru Sonpavde, Gregory R Pond, Jonathan E Rosenberg, et al.
Cell
|
July 8, 2022
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
Adrienne M Luoma, Shengbao Suo, Yifan Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 2026
Stereotactic Body Radiation Therapy With Pembrolizumab in PD-1 Inhibitor Refractory, Recurrent or Metastatic, Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial
Jonathan So, Alexander Droznin, Payal Tiwari, et al.
The Lancet. Oncology
|
July 6, 2023
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials
Claire L Vale, David J Fisher, Peter J Godolphin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
JAMA Oncology
|
August 28, 2020
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
Jonathan D Schoenfeld, Glenn J Hanna, Vickie Y Jo, et al.
International Journal of Antimicrobial Agents
|
June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020
Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.
The Lancet. Digital Health
|
May 27, 2026
Artificial intelligence analysis of temporalis muscle thickness for monitoring sarcopenia and clinical outcomes in individuals with paediatric brain tumours: a retrospective cohort study
Anna Zapaishchykova, John Zielke, Divyanshu Tak, et al.
Journal of Global Antimicrobial Resistance
|
July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020
Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
International Journal of Antimicrobial Agents
|
June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018
Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
Clinical Genitourinary Cancer
|
December 3, 2014
Complete response as an intermediate end point in patients receiving salvage systemic therapy for urothelial carcinoma
Guru Sonpavde, Gregory R Pond, Jonathan E Rosenberg, et al.
Cell
|
July 8, 2022
Tissue-resident memory and circulating T cells are early responders to pre-surgical cancer immunotherapy
Adrienne M Luoma, Shengbao Suo, Yifan Wang, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 11, 2026
Stereotactic Body Radiation Therapy With Pembrolizumab in PD-1 Inhibitor Refractory, Recurrent or Metastatic, Head and Neck Squamous Cell Carcinoma: A Phase 2 Trial
Jonathan So, Alexander Droznin, Payal Tiwari, et al.
The Lancet. Oncology
|
July 6, 2023
Which patients with metastatic hormone-sensitive prostate cancer benefit from docetaxel: a systematic review and meta-analysis of individual participant data from randomised trials
Claire L Vale, David J Fisher, Peter J Godolphin, et al.
International Journal of Radiation Oncology, Biology, Physics
|
August 12, 2020
A Randomized Phase 2 Study of Pembrolizumab With or Without Radiation in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma
Umair Mahmood, Andrew Bang, Yu-Hui Chen, et al.
JAMA Oncology
|
August 28, 2020
Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Untreated Oral Cavity Squamous Cell Carcinoma: A Phase 2 Open-Label Randomized Clinical Trial
Jonathan D Schoenfeld, Glenn J Hanna, Vickie Y Jo, et al.
International Journal of Antimicrobial Agents
|
June 24, 2021
In-vitro activity of cefiderocol, cefepime/zidebactam, cefepime/enmetazobactam, omadacycline, eravacycline and other comparative agents against carbapenem-nonsusceptible Enterobacterales: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2017-2020
Yu-Lin Lee, Wen-Chien Ko, Wen-Sen Lee, et al.
The Lancet. Digital Health
|
May 27, 2026
Artificial intelligence analysis of temporalis muscle thickness for monitoring sarcopenia and clinical outcomes in individuals with paediatric brain tumours: a retrospective cohort study
Anna Zapaishchykova, John Zielke, Divyanshu Tak, et al.
Journal of Global Antimicrobial Resistance
|
July 21, 2021
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020
Ying-Chun Chien, Yu-Lin Lee, Po-Yu Liu, et al.
International Journal of Antimicrobial Agents
|
June 17, 2019
Nationwide surveillance of antimicrobial resistance among clinically important Gram-negative bacteria, with an emphasis on carbapenems and colistin: Results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) in 2018
Yu-Lin Lee, Min-Chi Lu, Pei-Lan Shao, et al.
Page
of 18